ACY-1215

ACY-1215

CAT N°: 21531
Price:

From 108.00 91.80

ACY-1215 is an inhibitor of histone deacetylase 6 (HDAC6; IC50 = 5 nM).{33843} It is at least 10-fold less active against other HDACs in enzymatic assays. ACY-1215 shows synergistic activity with the proteasome inhibitor bortezomib (Item No. 10008822) against multiple myeloma (MM) cells, inducing protracted endoplasmic reticulum stress and apoptosis.{33843,33840} ACY-1215 combined with proteasome inhibitors suppresses tumor growth and increases survival in mice with MM and mantle cell lymphoma xenografts.{33840,33843,33842} A multicenter phase I trial examining ACY-1215 combined with the E3 ligase inhibitor lenalidomide (Item No. 14643) and dexamethasone (Item No. 11015) in multiple myeloma found inhibition of HDAC6 in vivo.{33845} ACY-1215 also diminishes liver cyst development and fibrosis in a rat model of polycystic liver disease.{33841}

We also advise you